¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß AI ½ÃÀå : ÄÄÆ÷³ÍÆ®º°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - ¿¹Ãø(-2030³â)
AI in Remote Patient Monitoring Market by Component, Indication, End User, Region - Global Forecast to 2030
»óǰÄÚµå : 1680999
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 324 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,162,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,621,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,792,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß AI ½ÃÀå ±Ô¸ð´Â 2024³â 19¾ï 6,770¸¸ ´Þ·¯¿¡¼­ 2030³â 84¾ï 3,850¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 27.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌÀ¯Ç÷·ù°¨¿°, ¿ä·Î°¨¿°, Æó·Å, C. difficile¿¡ ÀÇÇÑ °¨¿° µî º´¿ø ³» °¨¿°(HAI)¿¡ °É¸®´Â »ç¶÷ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °¨¿°Àº º´¿ø ³» ½É°¢ÇÑ °Ç°­ ÇÕº´Áõ ¹× »ç¸Á°ú °ü·ÃÀÌ Àֱ⠶§¹®¿¡ À§ÇèÀ» ¿¹¹æÇÏ°í °ü¸®Çϱâ À§ÇØ È¯ÀÚ¸¦ ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇÏ´Â ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ½ÉÇ÷°ü Áúȯ, ºñ¸¸, ´ç´¢º´°ú °°Àº ¸¸¼º ÁúȯÀÇ ¹ßº´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÎ ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ÀÇ ÀÇ·á ºñ¿ëÀº Å©°Ô ¾ÇÈ­µÇ°í ÀÖÀ¸¸ç, ¼ºÀÎÀÇ ¾à Àý¹ÝÀÌ Ã³¹æ¾à°ú ÀÇ»ç ¹æ¹® ºñ¿ë¿¡ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ CDC¿¡ µû¸£¸é, ÀÔ¿ø ȯÀÚ 31¸í Áß 1¸íÀº Àû¾îµµ ÇÑ ¹ø ÀÌ»ó ÀÇ·á °ü·Ã °¨¿°¿¡ °É·È´Ù°í ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, University of Pittsburgh Medical Center´Â RPM ÀåÄ¡°¡ º´¿ø ÀçÀÔ¿øÀ» 76% °¨¼Ò½ÃÄ×½À´Ï´Ù°í º¸°íÇß½À´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó ¿¬µµ 2022-2030³â
±âÁØ ¿¬µµ 2023³â
¿¹Ãø ±â°£ 2024-2030³â
°ËÅä ´ÜÀ§ ±Ý¾×(100¸¸ ´Þ·¯)
ºÎ¹® ±¸¼º¿ä¼Òº°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

¿þ¾î·¯ºí µð¹ÙÀ̽º´Â AI Áö¿ø ¹ÙÀÌ¿À¼¾¼­, ½º¸¶Æ®¿öÄ¡, ÀÇ·á¿ë ¿þ¾î·¯ºíÀÇ ¼ö¿ë È®´ë¿¡ ÈûÀÔ¾î 2023³â ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß¿¡¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â AI ½ÃÀåÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº ¸Ó½Å·¯´×, µö·¯´×, ¹ÙÀÌÅ» »çÀÎÀÇ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» ±â¹ÝÀ¸·Î ÀáÀçÀûÀÎ °Ç°­ ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇÏ°í ¿¹ÃøÀû ÅëÂû·ÂÀ» Á¦°øÇϸç, AI ±â¹Ý ½ÉÀüµµ ¸ð´ÏÅ͸µ, Ç÷´ç ¸ð´ÏÅ͸µ, ¿ø°Ý ÀǷḦ °¡´ÉÇÏ°Ô ÇÏ´Â ¿þ¾î·¯ºíÀÇ °³¹ßÀº ȯÀÚ Âü¿©¿Í ¸¸¼ºÁúȯ °ü¸®¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ȯÀÚ Âü¿©¿Í ¸¸¼ºÁúȯ °ü¸®¸¦ Áõ°¡½ÃÅ´À¸·Î½á ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 8¿ù MasimoÀÇ W1 Medical Watch´Â Masimo SafetyNet Telemonitoring System¿¡ ÅëÇÕµÇ¾î ½Ç½Ã°£ °Ç°­ ¿ø°Ý ¸ð´ÏÅ͸µÀ» À§ÇÑ FDA 510(k) ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß AI ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ 5°³ ÁÖ¿ä Áö¿ªÀ¸·Î ºÐ·ùµË´Ï´Ù. ºÏ¹Ì°¡ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀåÀ» Áö¹èÇϰí ÀÖ´Â ÀÌÀ¯´Â ¸î °¡Áö ¿äÀÎÀÌ Àִµ¥, ÇコÄÉ¾î ±â¼ú äÅ÷üÀÌ »ó´çÈ÷ ³ô°í, ÇコÄɾî ÀÎÇÁ¶ó°¡ źźÇÏ°Ô ±¸ÃàµÇ¾î ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ÁøÀüÀ» µÞ¹ÞħÇÏ´Â ÇコÄɾî ÁöÃâÀÌ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, 2023³â ÇöÀç ¹Ì±¹ ½ÄǰÀǾ౹(FDA)ÀÇ Æò°¡¸¦ °ÅÃÄ ½ÂÀÎÀ» ¹ÞÀº ÀÇ·á¿ë AI ±â±â´Â RPM °ü·Ã ÀÇ·á±â±â¸¦ Æ÷ÇÔÇÏ¿© 500°³ ÀÌ»ó¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ȯÀÚµéÀÇ ¸¸¼ºÁúȯ Áõ°¡¿Í ÀçÅÃÄ¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß AI ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ±¸¼º¿ä¼Òº°/ÀûÀÀÁõº°/ÃÖÁ¾»ç¿ëÀÚº°/Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ÇÁ¸®¹Ì¾ö ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß AI ½ÃÀå(ÄÄÆ÷³ÍÆ®º°)

Á¦7Àå ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß AI ½ÃÀå(ÀûÀÀÁõº°)

Á¦8Àå ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß AI ½ÃÀå(ÃÖÁ¾»ç¿ëÀÚº°)

Á¦9Àå ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ºÐ¾ß AI ½ÃÀå(Áö¿ªº°)

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ±â¾÷ °³¿ä

Á¦12Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The AI in remote patient monitoring market is projected to reach USD 8,438.5 million by 2030 from USD 1,967.7 million in 2024, at a high CAGR of 27.5% during the forecast period. Reason for growth in the AI in remote patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death in hospitals, hence the solutions that monitor patients remotely have been necessary in the prevention and management of risks. Further, the incidence of chronic diseases such as cardiovascular diseases, obesity, and diabetes is rising, which in turn increases the demand for effective remote monitoring technologies. The cost of healthcare in the US has substantially deteriorated; almost half of US adults are struggling to afford prescription drugs and doctor visits. According to US CDC about 1 in 31 hospital patients has at least one healthcare-associated infection. For instance, the University of Pittsburgh Medical Center reported that RPM devices reduced hospital readmissions by 76%.

Scope of the Report
Years Considered for the Study2022-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD Million)
SegmentsComponent, Indication, and End-user and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

"Wearable devices is the fastest growing segment in the AI in remote patient monitoring market by devices in 2023"

Wearable devices is expected to be the fastest-growing segment in the AI in remote patient monitoring market during 2023, due to the increasing acceptance of AI-enabled biosensors, smartwatches, and wearables for medical use. These devices are based on machine learning, deep learning, and continuous monitoring of vital signs, early detecting potential health issues, and supplying predictive insights. Other developments in AI-enabled ECG monitoring, glucose monitoring, and telehealth-enabling wearables are further supporting growth by increasing patient engagement and chronic disease management. For instance, in August 2024, Masimo's W1 Medical Watch received FDA 510(k) clearance to be incorporated into the Masimo SafetyNet Telemonitoring System for remote monitoring of health in real-time.

"North America dominated the remote patient monitoring market in 2023."

The AI in remote patient monitoring market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region dominated the remote patient monitoring market because of several factors such as substantially high adoption rates of healthcare technologies, a robust and well-established infrastructure in healthcare, and constant growth in healthcare spending that supports such progress. In addition, the increasing trend in the chronic diseases patients suffer from and the increasing need for home healthcare solutions will also increase growth in this region's market. As of 2023, over 500 medical AI devices have undergone U.S. Food and Drug Administration (FDA) evaluation and received approval including RPM related medical devices.

The break-down of primary participants is as mentioned below:

Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Healthcare, Inc. (Japan), GE HealthCare (US), Medtronic (Ireland), AliveCor, Inc. (US), NIHON KOHDEN CORPORATION (Japan), F. Hoffmann-La Roche Ltd (Roche Diagnostics) (Switzerland), Beijing Choice Electronic Tech Co. Ltd (US), Biobeat (Israel), Biotronik (Germany), and AccurKardia, Inc. (US) are some of the key players in the AI in remote patient monitoring market.

Research Coverage

This research report categorizes the AI in remote patient monitoring market by component (devices [wearable devices, implantable devices, handheld & portable devices, stationary devices]), software and services). By indication (oncology, cardiology, neurology, diabetes, sleep disorders, respiratory diseases, wellness improvement (weight management, fitness monitoring, hydration monitoring, nutritional tracking & monitoring, etc), mental health, and other indications (obstetrics, immunology, infectious diseases, ophthalmology, and others). By end user (healthcare providers [hospitals, ambulatory surgical centers, ambulatory care centers, and other outpatient settings, long term care & assisted living facilities, home healthcare, and other healthcare providers (diagnostics & imagining centers)], healthcare payers, patients, pharmaceutical & biotechnology companies, medTech companies, and other end users (employer groups, government organizations, academic institutes, research centers, and others)), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the AI in remote patient monitoring market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, agreements. new product & service launches, regulatory approval, investment, fundings, mergers and acquisitions, and recent developments associated with the AI in remote patient monitoring market. Competitive analysis of upcoming startups in the AI in remote patient monitoring market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the AI in remote patient monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT

7 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION

8 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER

9 AI IN REMOTE PATIENT MONITORING MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILES

12 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â